Atypical BCR-ABL mRNA transcripts in adult Acute lymphoblastic leukemia

Autor: Thomas Burmeister, Stefan Schwartz, Almut Taubald, Edgar Jost, Thomas Lipp, Folker Schneller, Helmut Diedrich, Henrike Thomssen, Ulrich J.M. Mey, Jan Eucker, Harald Rieder, Nicola Gökbuget, Dieter Hoelzer, Eckhard Thiel

Publikováno v: Haematologica, Vol 92, Iss 12 (2007)

RT-PCR detects chimeric BCR-ABL mRNA in approximately 25% of adult acute lymphoblastic leukemia (ALL) cases. Minor breakpoint transcripts (e1a2) are found in about 70% of positive cases and major breakpoint transcripts (e13a2, e14a2) in about 30% of

Externí odkaz: https://doaj.org/article/4b81c2dedc4f4bfd9a07148b9e5bfeef

Positron emission tomography-guided therapy of Aggressive Non-Hodgkin Lymphomas (PETAL): A multicenter, randomized phase III trial

Autor: Georg Maschmeyer, Martin Griesshammer, Stefan P. Müller, Helga Bernhard, Johannes Matschke, Dieter Hoelzer, Marcus Brinkmann, Aristoteles Giagounidis, André Scherag, J. rg Kotzerke, Heinz-Gert Höffkes, Gabriele Prange-Krex, Rolf M. Mesters, Wolfgang E. Berdel, Andreas Hertel, Ingo Brink, Uwe Haberkorn, Aruna Raghavachar, Christine Schmitz, Dorothea Kofahl-Krause, Thorsten Pöppel, Jan Dürig, Lilli Geworski, Bernd Hertenstein, Lars Kurch, Christiane Franzius, Martin Freesmeyer, Jan Rekowski, Frank Kroschinsky, Claudia Ose, Henrike Thomssen, Stefan Wilop, Paul La Rosée, Dirk Behringer, Jens Holzinger, Andreas Hüttmann, Tobias Gaska, Ulrich Dührsen, Frank M. Bengel, Andreas Bockisch, Karl-Heinz Jöckel, Daniëlle M. E. van Assema, Wolfram Klapper, Matthias Weckesser, Thomas Krohn

Publikováno v: Journal of Clinical Oncology, 36(20), 2024-2034. American Society of Clinical Oncology
Dührsen, U, Müller, S, Hertenstein, B, Thomssen, H, Kotzerke, J R, Mesters, R, Berdel, W E, Franzius, C, Kroschinsky, F, Weckesser, M, Kofahl-Krause, D, Bengel, F M, Dürig, J, Matschke, J, Schmitz, C, Pöppel, T, Ose, C, Brinkmann, M, la Rosée, P, Freesmeyer, M, Hertel, A, Höffkes, H-G, Behringer, D, Prange-Krex, G, Wilop, S, Krohn, T, Holzinger, J, Griesshammer, M, Giagounidis, A, Raghavachar, A, Maschmeyer, G, Brink, I, Bernhard, H, Haberkorn, U, Gaska, T, Kurch, L, van Assema, D M E, Klapper, W, Hoelzer, D, Geworski, L, Jöckel, K-H, Scherag, A, Bockisch, A, Rekowski, J & Hüttmann, A 2018, ' Positron emission tomography-guided therapy of Aggressive Non-Hodgkin Lymphomas (PETAL): A multicenter, randomized phase III trial ', Journal of Clinical Oncology, vol. 36, no. 20, pp. 2024-2034 . https://doi.org/10.1200/JCO.2017.76.8093

Purpose Interim positron emission tomography (PET) using the tracer, [18F]fluorodeoxyglucose, may predict outcomes in patients with aggressive non-Hodgkin lymphomas. We assessed whether PET can guide therapy in patients who are treated with cyclophos

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c1e22546a6c99e6903b85e8d9a006805
https://research.vumc.nl/en/publications/7ef7d468-6256-43ac-bf06-4ab9a2e7f4d1

Characteristics and Outcome of HIV-Associated Primary Effusion Lymphoma (PEL) As Observed in the German HIV-Related Lymphoma Cohort Study

Autor: Timo Wolf, Christoph Wyen, Johannes R. Bogner, Marcus Hentrich, Christian Hoffmann, Henrike Thomssen, Markus Mülller, Jan-Christian Wasmuth, Philipp Schommers

Publikováno v: Blood. 132:1719-1719

Introduction: Human immunodeficiency virus (HIV)-associated primary effusion lymphoma (PEL) is a rare and aggressive subtype of B-cell Non-Hodgkin lymphomas (NHL). PEL usually arises in body cavities such as the peritoneum, the pleural space, and per

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::4d83311341d4d2ab9901a013346de86e
https://doi.org/10.1182/blood-2018-99-118907

Die Medizin des Rufus von Ephesos

Autor: Henrike Thomssen, Christian Probst

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::b6263a21f9c10a5f5b1af1acae5258c0
https://doi.org/10.1515/9783110875393-005

Positron Emission Tomography Guided Therapy of Aggressive Non-Hodgkin's Lymphomas (PETAL trial): Correlation between Clinical Variables and PET Parameters

Autor: Henrike Thomssen, Gabriele Prange-Krex, Rolf M. Mesters, Frank Kroschinsky, Stefan Müller, Ulrich Duehrsen, Aristoteles Giagounidis, Andreas Hüttmann, Andreas Bockisch

Publikováno v: Blood. 114:2695-2695

Abstract 2695 Poster Board II-671 Introduction: Positron emission tomography (PET) performed after a few cycles of chemotherapy (interim-PET) in aggressive lymphomas correlates with long-term outcome: While the majority of patients with a negative in

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::c4e0d21acf8e0f85fa1e06fcd7e87eed
https://doi.org/10.1182/blood.v114.22.2695.2695